Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.

McNair, E; Marcoux, J-A; Bally, C; Gamble, J; Thomson, D

McNair, E; Marcoux, J-A; Bally, C; Gamble, J; Thomson, D.

Afiliación

McNair E; Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada Department of Surgery, Division of Cardiac Surgery, Saskatoon Health Region, Saskatoon, SK, Canada erick.mcnair@usask.ca.
Marcoux JA; Department of Surgery, Division of Cardiac Surgery, Saskatoon Health Region, Saskatoon, SK, Canada.
Bally C; Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Gamble J; Department of Anesthesiology and Pain Management, College of Medicine and Saskatoon Health Region, Saskatoon, SK, Canada.
Thomson D; Department of Surgery, Division of Cardiac Surgery, Saskatoon Health Region, Saskatoon, SK, Canada.

Perfusion ; 31(3): 189-99, 2016 Apr.

Article en En | MEDLINE | ID: mdl-25934498

Asunto(s)

Anticoagulantes/uso terapéutico; Procedimientos Quirúrgicos Cardíacos/métodos; Puente Cardiopulmonar/métodos; Resistencia a Medicamentos/efectos de los fármacos; Heparina/uso terapéutico; Fragmentos de Péptidos/uso terapéutico; Hirudinas; Humanos; Proteínas Recombinantes/uso terapéutico

Palabras clave

activated clotting time; bivalirudin; heparin; heparin concentration; heparin resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Resistencia a Medicamentos / Heparina / Puente Cardiopulmonar / Procedimientos Quirúrgicos Cardíacos / Anticoagulantes Límite: Humans Idioma: En Revista: Perfusion Asunto de la revista: CARDIOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google